Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate

Verify with FDA CVM →

112 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
112
Total Reports
0
Deaths Reported
0.0%
Death Rate

Active Ingredients

Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate

Administration Routes

UnknownAuricular (Otic)Oral

Species Affected

Unknown 59
Dog 49
Cat 4

Most Affected Breeds

Unknown 59
Retriever - Labrador 7
Dog (unknown) 5
Poodle - Miniature 3
Terrier - Yorkshire 3
Domestic Shorthair 3
Poodle - Standard 3
Lhasa Apso 3
Maltese 2
Mastiff 2

Most Reported Reactions

Dispenser, Abnormal 54
Uncoded sign 44
Hearing affected 24
Product Defect, General 10
Lack of efficacy - NOS 6
Underfilling, Tubes 4
Pinnal erythema 3
Underfilling, Package 3
Pinnal reddening 3
Pinnal irritation 3
Head shake - ear disorder 3
Vomiting 3

Outcome Breakdown

Recovered/Normal
32 (60.4%)
Outcome Unknown
16 (30.2%)
Recovered with Sequela
5 (9.4%)

Data Summary

Metric Value
Total adverse event reports 112
Reports involving death 0
Case-fatality rate (reported events) 0.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 112 adverse event reports referencing Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate, including 0 reports in which the animal died — a 0.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate. Reported administration routes include Unknown, Auricular (Otic), Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate reports are Unknown (59 reports), Dog (49 reports), Cat (4 reports), with Unknown accounting for the largest share. Within those species, Unknown (59), Retriever - Labrador (7), Dog (unknown) (5) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate are Dispenser, Abnormal (54), Uncoded sign (44), Hearing affected (24), Product Defect, General (10). Of the 53 reports with a coded outcome, Recovered/Normal is the leading category at 60.4%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Gentamicin Sulfate, Hydrocortisone Aceponate, Miconazole Nitrate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial